Cellectis (CLLS) Exits Two CAR-T Programs. Can Gene Editing Justify the Clinical Reset?
Cellectis S.A. (NASDAQ:CLLS) announced on September 14 that its board approved a strategic transformation on September 11.
Cellectis S.a. (CLLS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Long Focus Capital Management John B. Helmers | 2,741,853 | $8,225,559 | -1% | 0.21% |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 35,000 | $52,850 | 0.06% | |
| 2. | 495 | $747 | 0% | |
| 3. | 6 | $9 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Cellectis S.A. (NASDAQ:CLLS) Q2 2025 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q2 2025 Earnings Call Transcript August 5, 2025 Operator: Good day, everyone, and welcome to today's Cellectis' Second Quarter 2025 Earnings Call.
Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript November 5, 2024 Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2024 Earnings Call.
Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q3 2024 Earnings Call Transcript November 5, 2024 Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2024 Earnings Call.
Cellectis S.A. (NASDAQ:CLLS) Q1 2024 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q1 2024 Earnings Call Transcript May 30, 2024 Operator: Good morning, everyone, and welcome to the Cellectis First Quarter 2024 Earnings Call.
Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, everyone, and welcome to the Cellectis Third Quarter 2023 Earnings Calls. [Operator Instructions].
Cellectis S.A. (NASDAQ:CLLS) Q2 2023 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q2 2023 Earnings Call Transcript August 4, 2023 Operator: Good morning, and everyone, welcome to Cellectis Second Quarter 2023 Earnings Call.
Cellectis S.A. (NASDAQ:CLLS) Q1 2023 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q1 2023 Earnings Call Transcript May 5, 2023 Operator: Good morning, everyone, and welcome to Cellectis First quarter 2023 Earnings Call. [Operator Instructions].
Cellectis S.A. (NASDAQ:CLLS) Q4 2022 Earnings Call Transcript
Cellectis S.A. (NASDAQ:CLLS) Q4 2022 Earnings Call Transcript March 9, 2023 Operator: Good morning, everyone and welcome to Cellectis Fourth Quarter and Full Year 2022 Earnings Conference Call.
10 Genomics Stocks in Cathie Wood's Portfolio That Are Underperforming
In this article, we discuss 10 genomics stocks in Cathie Wood’s portfolio that are underperforming. ARK Investment Management is an innovation-focused hedge fund that is headquartered in St.
Hedge Fund Resource Center